Neurodegeneration and peripheral neuropathy are the major clinical consequence of human mutations affecting biosynthesis of the low abundance signaling lipid PI(3,5)P2. We have identified human and mouse mutations in the 3 major proteins of the PI(3,5)P2 biosynthetic complex: the phosphatase FIG4, the phosphokinase FAB1 (gene symbol PIKFYVE), and the scaffold protein VAC14. Neuronal expression of FIG4 is both necessary and sufficient to rescue neurodegeneration in brain and peripheral ganglia. Patients with Charcot-Marie-Tooth type 4J are compound heterozygotes for FIG4 mutations. The most common pathogenic variant in these patients is FIG4-I41T, which has an allele frequency of 0.001 in controls and destabilizes the protein, We will examine new patient cohorts by NextGen sequencing of pooled amplified exons, and carry out functional tests of rare patient variants of FIG4, VAC14 and FAB1 in cultured cells from mutant mice. As proof of principle for potential therapeutic interventions, we will examine the in vivo effects of overexpression of the transcription factor TFEB that regulates genes in the lysosome autophagy pathway. We will also evaluate treatment by up-regulation of the lysosomal cation transporter TRPML1, an effector of PI(3,5)P2 that rescues vacuolization of cultured fibroblasts from VAC14 null mice and is a potentially druggable target. We will use our floxed allele of Fig4 to distinguish the clinical contributions of motor and sensory neurons by conditional inactivation. We will investigate the functional properties of a novel mutation of FAB1 discovered in a large pedigree with Charcot-Marie-Tooth disease, as well as a novel variant of FIG4 discovered in a consanguineous pedigree with the neuronal migration disorder polymicrogyria. We will investigate the pathogenesis of intestinal obstruction in Fig4 deficient mice and its relevance to human patients. We will pinpoint the critical sites of PI(3,5)P2 dependence in the endocytosis lysosome pathway using markers of melanosome biosynthesis to dissect the pathway. The proposed experiments will integrate genetic analysis of pathogenic human mutations with functional dissection of PI(3,5)P2 activity to advance our understanding of the role of this pathway in human disease.
Neurons are long-lived cells that require robust protein turnover for maintenance of their network of axons and dendrites. Lysosomes and autophagy are important cellular components for protein turnover. We discovered that mutations in the gene FIG4 reduce protein turnover and neuronal survival. Patients with Charcot-Marie-Tooth Disease have mutations in FIG4. We developed mouse models of Charcot-Marie-Tooth disease that we will use to test two novel therapeutic targets. We will screen patients for defects in this pathway, and carry out functional testing of patient mutations, to test their role in this new clas of inherited neurological disorder.
|Menezes, Manoj P; Waddell, Leigh; Lenk, Guy M et al. (2014) Whole exome sequencing identifies three recessive FIG4 mutations in an apparently dominant pedigree with Charcot-Marie-Tooth disease. Neuromuscul Disord 24:666-70|
|Lenk, Guy M; Meisler, Miriam H (2014) Mouse models of PI(3,5)P2 deficiency with impaired lysosome function. Methods Enzymol 534:245-60|
|Baulac, Stéphanie; Lenk, Guy M; Dufresnois, Béatrice et al. (2014) Role of the phosphoinositide phosphatase FIG4 gene in familial epilepsy with polymicrogyria. Neurology 82:1068-75|
|Samie, Mohammad; Wang, Xiang; Zhang, Xiaoli et al. (2013) A TRP channel in the lysosome regulates large particle phagocytosis via focal exocytosis. Dev Cell 26:511-24|
|Campeau, Philippe M; Lenk, Guy M; Lu, James T et al. (2013) Yunis-Varon syndrome is caused by mutations in FIG4, encoding a phosphoinositide phosphatase. Am J Hum Genet 92:781-91|
|Vaccari, Ilaria; Dina, Giorgia; Tronchere, Helene et al. (2011) Genetic interaction between MTMR2 and FIG4 phospholipid phosphatases involved in Charcot-Marie-Tooth neuropathies. PLoS Genet 7:e1002319|
|Nicholson, Garth; Lenk, Guy M; Reddel, Stephen W et al. (2011) Distinctive genetic and clinical features of CMT4J: a severe neuropathy caused by mutations in the PI(3,5)P? phosphatase FIG4. Brain 134:1959-71|
|Lenk, Guy M; Ferguson, Cole J; Chow, Clement Y et al. (2011) Pathogenic mechanism of the FIG4 mutation responsible for Charcot-Marie-Tooth disease CMT4J. PLoS Genet 7:e1002104|
|Winters, Jesse J; Ferguson, Cole J; Lenk, Guy M et al. (2011) Congenital CNS hypomyelination in the Fig4 null mouse is rescued by neuronal expression of the PI(3,5)P(2) phosphatase Fig4. J Neurosci 31:17736-51|
|Yu, Ting; Shakkottai, Vikram G; Chung, Chan et al. (2011) Temporal and cell-specific deletion establishes that neuronal Npc1 deficiency is sufficient to mediate neurodegeneration. Hum Mol Genet 20:4440-51|
Showing the most recent 10 out of 97 publications